A investigationa clinical trial has revealed promising results for an innovative cell therapy approach to treating drug-resistant temporal lobe epilepsy.

A long-term study has revealed encouraging safety and efficacy data for azetukalner (XEN1101), an innovative anti-seizure medication designed for adults

A comprehensive new study has uncovered alarming evidence of cardiac abnormalities in people with epilepsy, potentially revolutionizing how doctors monitor

This randomized controlled trial has demonstrated that a structured self-management program can significantly improve outcomes for people living with epilepsy

A groundbreaking study from the University of Texas Health Science Center at Houston has demonstrated promising results for a neurostimulation

A comprehensive research study has unveiled important insights into the characteristics of epilepsy in adult patients who also experience developmental

A Phase 3 clinical trial has revealed that AXS-12 (reboxetine) significantly reduces cataplexy attacks and improves other symptoms in patients

A pioneering literature review by Colombian researchers has uncovered a potential connection between gut health and lower back pain, establishing

This neuroimaging study conducted by researchers at Massachusetts General Hospital and collaborating institutions has uncovered compelling evidence of brain inflammation

New research from the University of California suggests that measuring brain connectivity before surgery may help predict which epilepsy patients